Thursday, 17 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14409
Articles
Company
Drug
Merck’s Gardasil 9-Valent HPV Vaccine Approved for Expanded Age Range in China
February 11, 2025
Company
Deals
Onekdrug Raises Series B+ Funding to Boost Pharmaceutical B2B Services
February 11, 2025
Company
Drug
Sinocelltech’s Ripertamab Wins NMPA Approval for DLBCL Treatment
February 11, 2025
Company
Fosun Pharma’s H1 2022 Revenue Rises 25.9% on New Drug Launches, Global Expansion
February 11, 2025
Company
Drug
Clover Biopharma’s SCB-2019 Vaccine Shows Strong Immune Response to Omicron BA.5
February 11, 2025
Company
Drug
Staidson and J&J’s Teclistamab Gain Breakthrough Designation for Hemophilia and Myeloma
February 11, 2025
Company
Deals
Fosun Pharma to Invest RMB 1B in Chengdu Vaccine Base
February 11, 2025
Company
Drug
InnoCare Pharma and CStone Pharmaceuticals’ Drugs Receive Prioritized CDE Review
February 11, 2025
Company
Deals
Luca Healthcare Raises Pre-Series A Funding for Digital Biomarker R&D
February 11, 2025
Company
Drug
Biocytogen and Tracon Pharmaceuticals Gain FDA IND Approval for Sarcoma Trial
February 11, 2025
Company
Drug
Hengrui Medicine’s Dalpiciclib Hits Superiority Criteria in Phase III Study
February 11, 2025
Company
Ascentage Pharma’s H1 2022 Revenue Surges 636.9% on Olverembatinib Sales
February 11, 2025
1
2
…
1,142
1,143
1,144
1,145
1,146
…
1,200
1,201
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?